Atlas Trials

A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00555256 · COMPLETED

Trial details

NCT number
NCT00555256
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2007-11-01
Primary completion
2010-02-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.